Actually, you might as well add implied cash from the r&d rebate...

Actually, you might as well add implied cash from the r&d rebate fy22 of perhaps minimum 4m.

thats 35.9m dollars going for 29m.

I’ve seen stocks with negative ev that still struggle to go anywhere if the company doesn’t deliver something, anything of value to shareholders.

5M on last quarter and F-all share price wise to show for it.

glad GK got his 1M termination bonus though. Poor guy was on his pittance 600k+ salary before.

And yet I still believe in these people like a fool. Though I have no doubt that DS and GK are very smart people but it doesn’t mean they won’t fail in their endeavours. At the very least it seems life biosciences has stopped selling.

i would love to know if another biotech that currently trades at a negative EV.

fk it. I’m back on accumulation mode on Monday.

gltah and dyor